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OBJECTIVES The results of percutaneous balloon angioplasty for obstructed modified Blalock-Taussig
(BT) or central shunts and pulmonary artery (PA) stenoses were studied to assess its role as
an alternative to second shunt and surgical PA angioplasty.
BACKGROUND Obstruction of a modified shunt and PA stenosis related to the shunt or ductus are not
infrequent. A second shunt with or without PA angioplasty is required if the PA size,
morphology or age of the patient is suboptimal for definitive surgery.
METHODS From June 1994 to May 1999, balloon angioplasty for obstructed systemic-to-PA shunts was
performed in 46 patients, with ages ranging from 1 month to 7.4 years (2.2 6 1.9 years).
Among the 46 patients, 32 had modified BT shunts, 5 had bilateral shunts, 7 had modified
central shunts, and 2 had both modified BT and central shunts. Stenoses were seen in 27 main
branch PAs, and interruption was present in three. A concurrent balloon angioplasty was
attempted in 28 main branch PAs, but it was performed in only 25 vessels.
RESULTS Balloon dilation for obstructed modified shunts was considered to be effective in 42 patients
(91%), while angioplasty for PA stenosis was effective in 14 vessels and not effective in 11
vessels. After balloon dilation angioplasty, oxygen saturation in the aorta increased from
74.4 6 4.3% to 80.8 6 3.6% (p , 0.01) in these 46 patients. One patient died of pneumonia.
Eight patients required an additional modified BT shunt soon after the procedure because of
severe stenosis or interruption at main branch PA. After a mean follow-up period of 11.6 6
5.4 months, 29 patients underwent a repeated imaging study to evaluate the morphology and
size of the PAs. Of these 29 patients, 26 underwent open-heart surgery, with two mortalities.
CONCLUSIONS When a second shunt is under consideration because of obstruction of the modified shunt,
balloon angioplasty is a possible alternative procedure. Pulmonary artery stenosis, if present,
can be simultaneously dilated. (J Am Coll Cardiol 2001;37:940–7) © 2001 by the American
College of Cardiology
Primary repair in many congenital heart anomalies among
younger infants is on the increase. However, many patients
in early infancy still require a palliative systemic-pulmonary
artery shunt (1,2). The classic Blalock-Taussig (BT) shunt
is a widely accepted palliation for certain forms of congenital
heart disease where an increase in pulmonary blood flow is
required. A modified BT shunt, performed by placing a
See page 948
polytetrafluoroethylene (PTFE) tube between the pulmo-
nary artery (PA) and the subclavian artery, is increasingly
common because it provides satisfactory long-term results
with low morbidity (3–5). In some instances, a modified
central shunt is employed to palliate certain forms of
cyanotic heart disease (6). Occlusion or stenosis of a
systemic-PA shunt is not infrequent (7–9) and may result in
aggravated cyanosis. A second shunt may be required if the
PA size, weight or age of the patient is suboptimal for
definitive surgery. Balloon angioplasty for a stenosed classic
BT shunt has been performed with varied success (10–14).
However, reports of angioplasty for a systemic-PA PTFE
shunt are relatively rare (15–17). This study describes the
results of the dilation of obstructed PTFE shunts and
simultaneous angioplasty for PA stenoses in patients with
complex heart disease.
METHODS
Patients. The study protocol was approved by the human
research committee of this institution. Over a 60-month
period from June 1994 to May 1999, 70 patients in this
institution were diagnosed with a stenosed modified
systemic-PA shunt after cardiac catheterization and angiog-
raphy. Of them, 21 patients were considered as candidates
for definitive repair. The remaining 49 patients were judged
to require another palliative procedure before definitive
repair because of suboptimal PA size or suboptimal age.
Attempts to dilate the stenotic shunt failed with three
patients. Forty-six patients who underwent dilation of the
obstructed PTFE shunt were enrolled in this study. Their
ages ranged from 1 month to 7.4 years (2.2 6 1.9 years,
mean 6 standard deviation). Their body weight ranged
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from 3 to 18.1 kg (9.4 6 4 kg). There were 29 boys and 17
girls. Two patients were intubated with ventilatory support.
Seven patients required continuous infusion of PGE1 to
maintain O2 saturation above 75%. Eight patients required
continuous oxygen inhalation. Of the 46 patients, 32 had a
modified BT shunt; 5 had bilateral modified BT shunts; 7
had a modified central shunt, and 2 had a modified BT
shunt and a central shunt. The diameters of the shunts
implanted ranged from 3.5 mm to 6 mm. Among the 46
patients, 24 had main branch PA stenosis, and three had
interruption of a PA. Of the 24 patients with main branch
PA stenosis, the stenosis was found in 27 main branch PAs:
12 juxtaductal stenoses, 4 long segment hypoplasia of
central PAs, 9 shunt related stenoses and 2 multiple stenoses
related to both shunt and ductus. Dilation of the stenotic
lesions was attempted in 28 main branch PAs: 27 with
stenosis and one with acquired interruption.
Methods. All except seven patients who were younger than
two months received pre-medication with a cocktail of
meperidine, promethazine and chloropromazine 30 min
before cardiac catheterization. The seven patients who were
younger than two months were sedated with ketamine,
valium or dormicum. After local anesthesia, the femoral
vein and artery were percutaneously accessed. A 5F or 6F
sheath was used for cannulation of the femoral vein or
artery. Ketamine or dormicum was used as required. Hep-
arin 50 U/kg was routinely administered. After hemody-
namic studies, a selective angiogram at the distal subclavian
artery was obtained by employing a balloon occlusion
technique to delineate the site of obstruction in patients
with a modified BT shunt. The narrowest diameter of the
stenotic lesion in the modified BT shunt or subclavian artery
was measured in each patient. An angiogram of the aortic
root or descending aorta was performed on those with a
central shunt. After subclavian arteriography or aortogra-
phy, a right Judkins catheter (Cordis, Miami, Florida) or
head-hunter catheter (Balt, Montmorency, France) was
advanced to the PTFE graft. A soft tip 0.035 Radifocus
guidewire (Terumo Corp., Tokyo, Japan) was then posi-
tioned in the PA through the 4F or 5F right Judkins
catheter or head-hunter catheter. After retrieving that
catheter, a low profile (5F) short taper balloon catheter
(Schneider, Bulach, Switzerland) was advanced along the
guidewire to the stenotic lesion. The balloon was inflated
several times by applying a pressure of 3 to 8 atm. Each
inflation lasted ,10 s. For the sole patient with total
occlusion of the shunt, a floppy tip 0.014 coronary guide-
wire was gently advanced along the occluded PTFE graft,
and an ACS coronary balloon catheter (Advanced Cardio-
vascular Systems Inc., Temecula, California) was advanced
to the shunt to perform angioplasty. Then, progressively
larger balloon catheters were used to dilate the occluded
shunt. Of the five patients with bilateral modified BT
shunts, both shunts were dilated in two patients, and one
shunt was dilated in three patients. In the two patients with
both modified BT shunt and central shunt, the central shunt
was completely occluded, and the modified BT shunt was
dilated.
The interval between placing a modified shunt and an
attempted angioplasty ranged from 27 days to 6.8 years. The
size of the balloon used was generally equal to or slightly
larger than the shunt diameter. When the balloon catheter
selected could not pass the stenotic lesion, a balloon catheter
of a smaller size or coronary balloon catheter was used, then
progressively larger balloon catheters were employed. When
PA stenosis was present, the same guidewire was positioned
beyond the stenosis. Angioplasty for PA stenosis was
performed concurrently, employing the same balloon cath-
eter through the PTFE shunt. A pressure of 3 to 8 atm was
applied to inflate the balloon. Then, larger sized balloon
catheters were utilized to dilate the PA stenosis to the
desired diameter. The size of the balloon selected for PA
angioplasty was generally equal to or 1 to 2 mm larger than
the PA diameter proximal to stenosis. When the desired
size balloon catheter could not pass the PTFE shunt, a
smaller size balloon catheter was used. All patients were
monitored with pulse oxymeter and electrocardiogram dur-
ing cardiac catheterization and angioplasty procedure. A
postangioplasty angiogram was performed to evaluate the
effectiveness of angioplasty. The narrowest diameter of the
stenotic lesion of the modified BT shunt or subclavian
arteries was measured on the repeated angiogram. Fifteen
minutes after angioplasty, a second oxymetric study was
performed. In the eight patients requiring supplemental
oxygen before and during balloon angioplasty, repeat oxygen
saturations were measured while receiving the same frac-
tional inspired oxygen. We arbitrarily defined effective
balloon dilation for obstructed modified shunts as an in-
crease in the shunt diameter $20% or increase in systemic
O2 saturation $3%. We also defined effective PA angio-
plasty as an increase in diameter of PA .50%. For patients
with multiple stenoses in one vessel, an increase .50% in all
stenotic lesions was regarded as effective angioplasty.
Statistical analysis. Data are expressed as mean 6 stan-
dard deviation. A paired t test was used to compare the
systemic O2 saturation data, diameter of narrowest dimen-
sion in a modified shunt and PA before and after angio-
plasty and the McGoon ratio and narrowest dimension in a
shunt and PA after angioplasty and preoperative evaluation.
RESULTS
Balloon angioplasty for stenosed shunts and pulmonary
arteries. Information about these 46 patients is listed in
Table 1. A flow chart was also provided (Fig. 1). All patients
Abbreviations and Acronyms
BT 5 Blalock-Taussig
PA 5 pulmonary artery
PTFE 5 polytetrafluoroethylene
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tolerated the procedure. Of the seven patients with a central
shunt, the stenosis occurred at the anastomotic sites or graft.
Of the 39 patients with a modified BT shunt, stenosis was
confined to a subclavian artery in 5, in the graft alone in 9,
at the anastomotic sites in 6, in both graft and anastomotic
site in 12 and in both the subclavian artery and graft in 7.
The balloon-to-PTFE tube diameter ratio ranged from 0.8
to 1.5 (mean 1.13 6 0.17). Postangioplasty subclavian
arteriograms or aortograms confirmed that the stenoses in
the PTFE shunts or subclavian arteries were partially or
completely relieved in all 46 patients (Fig. 2). Excluding the
seven patients with a central shunt in whom measuring the
dimension of stenotic lesion was suboptimal, the mean
diameter of the stenotic lesions in the grafts or subclavian
arteries increased from 2.2 6 0.7 mm to 3.2 6 0.6 mm (p ,
0.01) after balloon angioplasty in the 39 patients with
modified BT shunts. Judging from the postangioplasty
angiogram, pulmonary blood flow increased in most pa-
tients. Balloon angioplasty for the modified shunt was
considered effective in 42 patients (91%) and ineffective in
four patients. Dilation of PA stenosis or interruption was
accomplished in 25 main branch PAs, but failed in three.
The causes of technical failure in the three vessels were:
inability to pass a floppy guidewire across the stenotic lesion
in two vessels and failure to pass a balloon in one vessel.
Excluding the patient with acquired interruption of right
PA, the ratio of balloon size to narrowest diameter of PA
stenosis ranged from 1.8 to 3.1 (2.3 6 0.5). In the 25
vessels, the mean diameter of the stenotic PA segment
increased from 2.8 6 1.3 mm to 4.5 6 1.9 mm (p , 0.01)
after angioplasty. Dilation of PA stenosis was considered to
be effective in 14 vessels where perfusion to PAs distal to the
stenotic lesion was significantly increased after dilation (Fig.
3). Of the 11 vessels with ineffective PA angioplasty, four
were long-segment central PA hypoplasia, two were shunt
related stenosis, two were juxtaductal stenosis, two were
multiple stenoses, and the remaining one was an acquired
interruption of the right PA after a modified shunt in which
there was significant stenosis requiring another shunt.
After the angioplasty, the mean oxygen saturation in the
aorta increased from 74.4 6 4.3% to 80.8 6 3.6% in these
46 patients (p , 0.01). All except one had an increase in
systemic O2 saturation ranging from 2% to 15%. The sole
patient, who had a slight decrease in systemic O2 saturation












OutcomeFeasibility Effectiveness Before After
I. Univentricular AV Connection or Complex Cardiac Anomalies
1 F 4 DILV, L-TGA, PA LPA 1 1 72 83 TCPC
2 F 1.2 PA-IVS 73 83 Lost to follow-up
3 M 2 TA, PS, VSD 66 76 Expired
4 F 3.8 RAI, AVC, DORV,
PS
76 82 TCPC
5 M 7.3 DILV, L-TGA, PS LPA 1 1 79 84 Ventricular septation,
expired
6 M 3.8 SI, DIRV, DORV,
PS
77 83 TCPC
7 M 1.5 RAI, DIRV, PA LPA 2 72 79 BTS then BCPS
8 M 0.2 RAI, AVC, PA 66 74 Expired
9 F 4.1 SI, MA, PA LPA 1 2 82 84 BCPS, then
transplantation
10 M 1.5 RAI, AVC, PA,
TAPVC
LPA int 70 82 BTS, then BCPS
11 M 1.5 RAI, DIRV, PA RPA 1 1 79 84 BCPS
12 F 3.5 RAI, DIRV,
DORV, PS,
TAPVC
79 84 TAPVC reroute and shunt
13 M 0.3 SI, MA, PA RPA 2 75 77 TCPC
14 M 0.5 RAI, AVC, PA,
TAPVC
77 86 Expired
15 M 0.4 MA, DORV, PS 74 72 O2 saturation 76%




17 F 3.5 PA-IVS LPA 1 1 75 80 BCPS
18 M 0.1 HLHS 70 76 O2 saturation 78%
19 M 2 RAI, AVC, PA RPA int 2 74 77 BTS
20 F 6.8 RAI, AVC, DORV,
PS, TAPVC
LPA 1 1 73 80 BTS
(continued on next page)
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immediately after angioplasty, had a significant increase in
systemic O2 saturation measured with pulse oxymetry on
the next day. The PGE1 could be discontinued in the five of
seven patients within seven days. The remaining two had
required another shunt because of juxtaductal coarctation of
a PA. One of the two patients who was intubated with
ventilatory support could not be weaned from the respirator
and died of pneumonia. Of the eight patients requiring O2
inhalation, the oxygen could be discontinued after the
procedure in six patients. A total of eight patients under-
went a modified BT shunt soon after the procedure because
of a severe stenosis or interruption in a PA. The remaining
37 patients were discharged with antiplatelet therapy (aspi-
rin: 5 mg/kg/day).
Complications. No severe complications were encoun-
tered. No patient developed hemoptysis. Intimal tear of a
PA was found in seven patients. A distal branch PA was
occluded after angioplasty in one patient (Fig. 4). A tran-
sient drop in O2 saturation was experienced in 38 patients
who were treated by O2 inhalation through a mask or hood
and prompt withdrawal of the balloon catheter to the aorta.
Six patients required heparin or streptokinase infusion
because of transient loss of a femoral pulse.
Follow-up. During follow-up, one patient died of an
accident, and one patient with asplenia syndrome died of an
overwhelming infection. One patient was lost to follow-up.
Twenty-nine patients underwent imaging studies for PA
size and morphology 6 to 26 months (11.6 6 5.4 months)
after the initial intervention: four patients with a comput-
erized tomography and 25 patients with an angiogram. The
shunts that were dilated in previous balloon angioplasty
were patent in all except one patient with complete occlu-
sion. Two had recurrent stenosis of the shunt. In 23 patients













OutcomeFeasibility Effectiveness Before After
II. TOF or DORV Type
21 M 1.3 TOF, PA LPA 1 2 72 81 BTS and pulmonary artery
augmentation
22 F 4.1 TOF, PA RPA 1 1 72 86 Rastelli
23 F 2.2 TOF, PA 73 88 RVOT patch
24 F 2.5 TOF, PA LPA 1 2 80 86 Rastelli
RPA 1 1
25 M 0.2 TOF, PA RPA 1 1 70 75 O2 saturation 76%
26 F 2.1 TOF, PA LPA 1 1 80 82 O2 saturation 81%
27 F 0.3 TOF RPA int 1 2 75 83 BTS
28 M 4.9 TOF, PA RPA 1 2 78 82 BTS
LPA 2
29 M 0.9 DORV, PA, VSD LPA 1 2 75 80 Rastelli
30 F 5.6 TOF, PA 78 80 O2 saturation 79%
31 M 2.7 TOF, PA 80 82 Rastelli
32 M 0.1 TOF LPA 2 68 74 O2 saturation 84%
33 F 1.2 TOF, distal ductal
origin of LPA
77 80 Total repair
34 M 1.4 TOF LPA 1 1 81 85 Total repair
35 M 2.6 TOF, PA LPA 1 1 76 83 Rastelli
36 M 0.2 TOF, PA LPA 1 2 77 78 BTS
37 F 3.5 TOF, PA LPA 1 1 74 82 Rastelli
38 M 2.1 TOF, PA 77 83 O2 saturation 81%
III. TGA or Corrected TGA With PS or PA
39 M 1.1 RAI, AVC, DORV, PS,
TAPVC
73 80 Double switch
40 M 7.4 Corrected TGA, SI,
VSD, PA
LPA 1 2 79 84 Rastelli
RPA 1 2
41 F 1.5 Corrected TGA, VSD,
PA
RPA 1 1 78 82 Double switch, expired
42 M 1.6 TGA, VSD, PS LPA 1 2 67 78 BTS
43 M 1.8 SI, corrected TGA, PA RPA 1 1 71 77 Double switch
44 F 0.7 TGA, VSD, PS 69 83 O2 saturation 80%
45 M 0.2 TGA, VSD, PS 65 76 O2 saturation 78%
46 M 2.8 TGA, VSD, PS 72 80 Kawashima procedure
AV 5 atrioventricular; AVC 5 atrioventricular canal defect; BCPS 5 bidirectional cavopulmonary shunt; BTS 5 modified Blalock-Taussig shunt; DILV 5 double-inlet left
ventricle; DIRV 5 double-inlet right ventricle; DORV 5 double-outlet right ventricle; HLHS 5 hypoplastic left heart syndrome; int 5 interruption; IVS 5 intact ventricular
septum; L 5 levo; LPA 5 left pulmonary artery; MA 5 mitral atresia; PA 5 pulmonary atresia; PS 5 pulmonary stenosis; RAI 5 right atrial isomerism; RPA 5 right pulmonary
artery; RVOT 5 right ventricular outflow tract; SI 5 situs inversus; TA 5 tricuspid atresia; TAPVC 5 totally anomalous pulmonary venous connection; TCPC 5 total
cavopulmonary connection; TGA 5 transposition of the great arteries; TOF 5 tetralogy of Fallot; VSD 5 ventricular septal defect; 1 5 Yes; 2 5 No.
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stenotic lesion in the modified BT shunt was 3.1 6 1.1 mm,
compared with the mean diameter 3.3 6 0.7 mm measured
immediately after angioplasty; there was no significant
difference (p 5 0.34). Of the 18 PAs that were dilated in a
previous angioplasty, the mean diameter of the narrowing
segment increased from 5 6 1.8 mm after angioplasty to
5.4 6 1.8 mm on the follow-up angiogram (p , 0.05). No
restenosis occurred in the PAs in which previous balloon
angioplasty was effective. One patient underwent a concom-
itant PA balloon angioplasty with further increase in diam-
eter of the stenotic lesion (Fig. 5). An aneurysm, which was
not detected in previous angioplasty, was found at the
anastomotic site of a shunt in a PA in one patient.
Excluding the two patients with interruption of a PA, the
McGoon ratio (sum of the diameter of left and right PA
before first lobar branches/the diameter of the descending
aorta at the level of diaphragm) increased from a mean of
1.49 6 0.2 before angioplasty to 1.58 6 0.16 (p , 0.01) at
follow-up in the 27 patients. Of the 29 patients, 26
underwent an open-heart surgery: four for total cavopulmo-
nary connection, six for bidirectional Glenn shunt, seven for
Rastelli operation, one for ventricular septation, three for
double switch, one for Kawashima procedure, one for right
ventricular outflow tract patch, one for rerouting of pulmo-
nary venous confluence to atrium and a shunt implantation
and two for repair for tetralogy of Fallot. Of the 26 patients,
a concurrent PA angioplasty was performed in eight pa-
tients. There were two mortalities. One patient underwent
a modified BT shunt and PA augmentation because of a
long segment central PA stenosis and inadequate PA index.
Two patients await open-heart surgery. One patient (Pa-
tient 15) who survived bidirectional cavopulmonary shunt
and PA reconstruction developed severe atrioventricular
valve regurgitation and impaired ventricular function. She
underwent a cardiac transplantation with success. Excluding
those who underwent a surgery, there were nine patients
available for follow-up. After a mean follow-up period of
7.8 6 6.3 months; the mean O2 saturation measured with
pulse oxymeter was 79.2 6 2.6% in these nine patients.
Figure 1. A flow chart of the 46 patients in whom balloon angioplasty for
obstructed shunt was performed. F/U 5 follow-up.
Figure 2. Left side panels: A, C, E, G: angiograms at a subclavian artery
showing stenosis (arrow) at the subclavian artery (A), stenosis (arrow) at
anastomotic site of subclavian-to-graft (C), stenosis in graft (E) and
graft-to-pulmonary artery stenosis (curved arrow) (G). There were shunt-
related pulmonary artery stenoses noted on panels C and G (arrow). Right
side panels: B, D, F, H (after angioplasty): repeat angiograms at the
subclavian artery after angioplasty showing stenoses at the subclavian artery
(arrow) (B), anastomotic sites (D and H) and graft (F) were relieved.
There was dissection (white arrow) in the subclavian artery noted on panel
D. The shunt-related pulmonary artery stenosis was partially relieved after
a concurrent angioplasty using a larger size balloon (panel H).
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DISCUSSION
Dilation of PTFE shunts as an alternative to a second
shunt. The percutaneous balloon dilation technique has
been widely employed to treat congenital valvular and
vascular stenosis with satisfactory results (18). This tech-
nique has been successfully applied in patients with stenosed
standard BT shunts and can be an alternative procedure to
a second shunt (10–14). Therefore, a standard BT shunt is
recommended as the first choice of systemic to PA shunt
because it is uniquely dilatable (14). In this study, dilation
for stenosed modified shunts, which was accomplished in 46
of 49 patients, was effective in 42 patients (91%). A
modified BT shunt or a modified central shunt is advocated
as an initial palliation in complex cyanotic heart disease
because dilation can be performed in most patients with
stenosis of the modified shunts. An effective dilation for a
stenosed PTFE shunt may eliminate the need for a second
shunt, particularly for patients with complex heart disease in
whom further PA distortion may occur after a shunt
(15–17,19). Although the bidirectional cavopulmonary
shunt and a concurrent PA angioplasty have been recom-
mended for infants who are Fontan-type surgery candidates
Figure 3. (A) Significant stenosis related to a ductus at the right pulmonary artery is illustrated. (B) After balloon angioplasty, pulmonary artery stenosis
was relieved.
Figure 4. (A and B) A selective angiogram illustrating multiple stenoses,
(arrowheads) in the modified Blalock-Taussig shunt in a patient who
underwent unifocalization of the pulmonary arteries. There were stenoses
in distal pulmonary arteries. (C and D) After angioplasty, the stenoses in
the shunt were relieved with increased pulmonary blood flow. There was
occlusion of a left distal pulmonary artery (arrow).
Figure 5. (a) Significant stenosis (arrowhead) at the left pulmonary artery
related to a modified Blalock-Taussig shunt is shown. Balloon dilation was
performed in this patient. (b) A repeated pulmonary arteriogram 18
months after balloon angioplasty showing mild stenosis (arrowhead) at the
left pulmonary artery. (c) After the repeated angioplasty, the stenosis at the
left pulmonary artery was completely relieved.
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(20), balloon dilation of the obstructed shunt and the
stenosed PA can serve as an alternative procedure.
Technical aspects and complications of dilating stenosed
modified shunts. Stenosis of the modified PTFE shunt
can occur in the subclavian artery adjacent to the anasto-
motic site, the graft and anastomotic sites. The stenosis at
the anastomotic site may result from scar formation, while
the stenosis in the PTFE tube may be due either to fibrous
neointimal peel or to organized thrombosis (17). The
mechanism of the action of balloon angioplasty in dilation
of the PTFE tube may involve dissection and disruption of
the fibrous neointimal peel or thrombi. Employing a balloon
slightly larger than the graft diameter appears to be bene-
ficial and safe although an aneurysm at the anastomotic site
of a PTFE tube and the PA was seen in one patient. This
could be the result of a tear at the anastomotic site.
Dislodgment of intimal lining causing thrombosis of a distal
branch PA could be a problem after dilation of the modified
shunt. In the patient who developed obstruction of a distal
branch of a PA, a right ventricular outflow tract reconstruc-
tion was performed without any major complication. In this
study, the interval between a shunt placement and balloon
angioplasty was no less than three weeks because immature
scar tissue may not tolerate dilation with high pressure and
an oversized balloon, which was selected for dilating both
the shunt and PA (21). For balloon angioplasty for early
postoperative shunt failure, a balloon with a diameter
smaller than the shunt has been recommended (16). Ad-
vancing a catheter to a modified BT shunt at the left
subclavian artery via a retrograde aortic route in a patient
with a right aortic arch can be difficult. An anterograde
route from the femoral vein to the aorta is a possible
alternative approach in such patients with double outlet
right ventricle or tetralogy of Fallot (14). A modified central
shunt can be entered with a right coronary catheter without
much difficulty, but successful balloon angioplasty for a
modified central shunt has rarely been reported in literature.
There was failure in balloon angioplasty for stenosed PTFE
shunts, which occurred in early experience here. Since early
1995, after the procedure has become more familiar, almost
every case has been successful.
Simultaneous dilation of pulmonary artery stenosis. Pul-
monary artery distortion after a systemic-PA shunt is
common (7,8,19). Pulmonary artery stenosis related to
ductus is also frequent in complex cyanotic heart disease
(22–24). In the presence of PA stenosis, growth of the PA
distal to stenosis can be hampered. A successful angioplasty
may provide relief of PA stenosis or improve perfusion to
the underperfused lung and growth of distal PA, greatly
increasing the chances for later Fontan-type or Rastelli
surgery (21). Surgical angioplasty for PA stenosis related to
a ductus or shunt may be a problem and, for this reason,
balloon dilation of PA stenosis before definitive surgery
would be an alternative to surgical reconstruction of PAs
(22–25). Several complications from balloon angioplasty for
PA have been reported in literature including aneurysm,
hemoptysis, heart block and death (21,26). Tearing in
intima and media, which was not infrequent after balloon
angioplasty, was a mechanism and also a predictor for
successful PA angioplasty (26,27). The success rate of
angioplasty for branch PA stenosis was reported to be 58%
(21). In two reports, surgery-related PA stenosis was con-
sidered to be amenable to balloon dilation (27,28). In a
report by Gentles et al. (26), using a high-pressure balloon
in dilation of surgery-related lesions was nearly always
successful. In this study, balloon angioplasty for PA stenosis
was performed through a modified shunt. Branch PA
stenosis was effectively dilated in 14 of 28 attempts (50%).
The balloon size selected in this study was generally smaller
than those recommended in literature (21,26). This was
attributed to the relatively smaller caliber of PTFE shunt
allowing for passage of smaller size balloons. Balloon
angioplasty for neonates or young infants with ductus-
related PA stenosis may not provide long-term relief of
stenosis, because closure and fibrosis of ductal tissue may
lead to restenosis (24). Restenosis of PA to pre-dilation size
occurred in 10% to 16% of patients (21,26). In this series, no
restenosis was detected in the PAs, which were effectively
dilated.
Study limitations. There were several limitations in this
study. This is a retrospective study. The definitions of
success in angioplasty for stenosed shunts and PA stenosis
are quite arbitrary. We used an increase in shunt diameter
$20% or systemic O2 saturation $3% as criteria for
effective dilation for shunts. However, the increase in
systemic O2 saturation after the procedure cannot be attrib-
uted to the effect of dilation for the shunts alone. A
concurrent angioplasty for PA stenosis may also contribute
to the relief of hypoxemia. An increase of PA diameter
.50% may not be a perfect criterion for effective PA
angioplasty. In many patients with effective angioplasty,
there are varying degrees of PA stenosis left that may
compromise later Fontan circulation. Eight patients in the
current series required a patch angioplasty for PAs at the time
of an open-heart surgery. Understanding the long-term effects
of balloon angioplasty for branch PA stenosis requires further
studies. We observe that many of the patients may need an
endovascular stent placement in the future (29).
Conclusions. When a second shunt is under consideration
because of obstruction of a PTFE shunt, balloon angioplasty
to dilate the stenotic sites may be an alternative to another
shunt. Balloon dilation for a PA stenosis, either ductus or
shunt-related, can be performed concurrently. This is par-
ticularly true for patients who are candidates for Fontan-
type surgery, because a second shunt may incur risk and
further distort PAs.
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